Novartis Pharmaceuticals UK Ltd
Every public sector contract Novartis Pharmaceuticals UK Ltd has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Novartis Pharmaceuticals UK Ltd for you, and alerts you the moment a renewal goes live.
Where they win
The sectors, tender types and buyers where Novartis Pharmaceuticals UK Ltd wins most often.
See every live NHS tenders and find your next contract before they do.
Similar suppliers
See all NHS buyers and UK contract awards.
Sectors
Top Buyers
Awards(36)
SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack
REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet
Utathera 7400MBq/20.5-25ml solution
solution for infusion vial
TRAMETINIB 2MG TABLETS, 30 tablet, pack
Contract for Netspot (Gallium Ga 68 Dotatate)
PRRT (Peptide Receptor Radionuclide Therapy)
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
NETSPOT DOTATATE
MIDOSTAURIN 25MG CAPSULES
MIDOSTAURIN 25MG CAPSULES, 56 capsules, pack
IPTACOPAN HYDROCHLORIDE MONOHYDRATE 200MG CAPSULES, 56 capsules, pack
Asciminib Tablets, 60 tablet pack
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack
RIBOCICLIB 200 mg Tablets 63 Tablet Pack
NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections
SIPONIMOD 2 mg Tablets 28 Tablet Pack
NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024
Why track Novartis Pharmaceuticals UK Ltd?
Novartis Pharmaceuticals UK Ltd is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.
How renewal tracking works
We aggregate Novartis Pharmaceuticals UK Ltd's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.
What you can do here
- Review the full history. Every contract Novartis Pharmaceuticals UK Ltd has won, with the buyer, value and dates for each.
- Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
- Track and get alerted. Follow Novartis Pharmaceuticals UK Ltd and be notified when their contracts come up again (Business).
- Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.
Frequently asked questions
Where does this data come from?
Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.
Is the contract history free?
Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.
How do you predict renewals?
From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.